Category: Abbott LaboratoriesSyndicate content

Abbott buys into electrophysiology with $250m Topera acquisition

October 29, 2014 by Brad Perriello

Abbott pays $250 million plus milestones for Topera Medical and its cardiac arrhythmia mapping technology and inks a deal to acquire Advanced Cardiac Therapeutics and its ablation catheter.

Abbott buys into electrophysiology with $250m Topera acquisition

Abbott to go ahead with $5.3B Mylan deal, says 3rd-quarter sales match forecasts

October 22, 2014 by MassDevice

Abbott says it will go ahead with its plan to deal its generic pharmaceuticals line to Mylan for $5.3 billion and reports 3rd-quarter sales in line with expectations.

Abbott to go ahead with $5.3B Mylan deal, says 3rd-quarter sales match forecasts

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA reverses stance on reporting requirement | Regulatory news for the week of October 20, 2014

October 21, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: FDA yanks enhancement reporting requirement; FDA approves Medtronic's full-body MRI-safe lead; FDA strikes out again in Prevor drug-or-device case; Abbott inks co-distribution deal with Carl Zeiss Meditec; Boston Scientific wins CE Mark for Accolade MRI-safe pacemakers

FDA yanks enhancement reporting requirement

October 15, 2014 by Brad Perriello

Abbott inks co-distribution deal with Carl Zeiss Meditec

October 17, 2014 by Brad Perriello

Abbott says it inked a non-exclusive deal to sell Carl Zeiss Meditec's cataract surgery products alongside its own eye surgery offerings and announces FDA clearance for a pair of laser cataract surgery devices.

Abbott inks co-distribution deal with Carl Zeiss Meditec

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Mazzo suspended at Versant Ventures after insider trading indictment | Personnel Moves

October 15, 2014 by Brad Perriello

James Mazzo and Versant Ventures agree to suspend Mazzo after his indictment on insider trading charges stemming from Abbott's $2.8 billion acquisition of Advanced Medical Optics.

Mazzo suspended at Versant Ventures after insider trading indictment | Personnel Moves

Versant Ventures and James Mazzo agreed that Mazzo will "suspend any activities" at the venture capital shop following his indictment last month on insider trading charges.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic shareholder sues over company's plan to cover nearly $58M in taxes | Medtech legal news for the week of October 13, 2014

October 13, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Shareholder sues Medtronic over plan to cover execs' $58m tax tab; Report: Bard's mesh settlement is worth $21m; Covidien's Ev3 logs a pair of legal wins over Appriva, whistleblower; BD loses bid to overturn $114m antitrust loss to Retractable Technologies; Ex-Oriole DeCinces fights insider trading charges

Shareholder sues Medtronic over plan to cover execs' $58m tax tab

October 7, 2014 by Brad Perriello

Feds fight dismissal of charges in Abbott-AMO insider trading case

October 10, 2014 by Brad Perriello

Federal prosecutors fight a move by ex-Orioles baseballer Doug DeCinces to have charges dropped from the insider trading case involving ex-Advanced Medical Optics CEO James Mazzo, who's accused of passing along inside info on Abbott's $2.8 billion AMO buyout.

Feds fight dismissal of charges in Abbott-AMO insider trading case

Federal prosecutors are fighting a bid by Doug DeCinces, the ex-Orioles player accused of insider trading on information he got from former Advanced Medical Optics CEO James Mazzo, to have a raft of charges dropped from his indictment.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp